News Articles


From primary to malignant - what changes?

Malignant transformation_Frida.jpg

Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model

From primary to malignant - what changes? Bridging transcriptomics and proteomics to reveal the molecular changes during malignant transformation in a four-step cancer cell line model

In order to find out more about the changes that occur when a primary cell is transformed into an aggressive cancer cell, integration of biological information has proven to be successful. By bridging transcriptomics and antibody based proteomics data we showed how the major changes during malignant transformation could be scrutinized...Read more


Upcoming Events


Flow Cytometry & Imaging from single cell to the patient

November 14, 2018 - November 14, 2018

Dr Charlotte Stadler is Plenary Keynote Speaker presenting "An image based subcellular map of the human proteome" at the The 6th biennial Pharmaceutical Flow Cytometry and Imaging meeting, Stevenage, UK.
Overview

2018 ASCB | EMBO Meeting

December 8, 2018 - December 12, 2018

The Human Protein Atlas will be exhibiting at the 2018 ASCB EMBO meeting in San Diego. In booth number #624 you will meet the Cell Atlas team Emma Lundberg, Christian Gnann, Lovisa Ã…kesson and Peter Thul. They will also present four posters.
Preliminary programme